Tag Archives: Pharma
Social Media and Healthcare Consumers: A Report
In the past decade, social networking has changed the way most of us live our day-to-day lives. So how has it affected pharma’s relationship with consumers, and vice versa? A recent report from ROI Research grants a glimpse into this changing relationship.
Social networking is no longer something people (patients, healthcare providers, physicians) are merely talking [...]
Posted in E-Media, Technology, social media Also tagged consumers, healthcare, online, social media Leave a comment
What Is Behind the Genzyme Job Cuts?
Troubled biotech Genzyme’s (Cambridge, MA) planned elimination of over 1,000 jobs (10% of its 12,800 workforce, according to the Boston Globe) over the next 15 months is not related to the takeover bid from French giant Sanofi Aventis, the company has said.
Posted in Deals, Global, Strategy Also tagged Deal, Genzyme, layoffs, mergers, pharmaceutical industry, takeover Leave a comment
Patients Want to Talk. Do You?
Why are companies rushing to the web when traditional engagement with patient groups remains so under-exploited, asks Jacky Law.
It used to be so easy. Patients listened to doctors, doctors listened to pharma and everyone was happy. There was even a time when payers listened to pharma, reimbursing their prices with very few questions asked. Now [...]
Posted in E-Media, Europe, FDA, Global, Guest Blog, Legal Also tagged patient communication, patient education, patient groups, Regulatory, social media 2 Comments
Nothing is Rotten in the State of Denmark
Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent.
Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defence policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast [...]
Posted in Europe, Global, Guest Blog, Regulatory Also tagged code of practice, Denmark, Europe, European Commission, European Union, LIF, transparency Leave a comment

Pharma Gets the ProPublica Treatment